Y-Intercept »

Nurix Therapeutics shares owned by Y-Intercept

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Y-Intercept

Quarter filed Position value Share count Share price at filing
2024-09-30 $346k 15k 22.47

More positions owned by Y-Intercept

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Jd.com Spon Ads Cl A (JD)
Spotify Technology S A SHS (SPOT)
Eli Lilly & Co. (LLY)
Ke Hldgs Sponsored Ads (BEKE)
Vale S A Sponsored Ads (VALE)
Otis Worldwide Corp (OTIS)
Microstrategy Cl A New (MSTR)
CVS Caremark Corporation (CVS)
Carrier Global Corporation (CARR)
Regeneron Pharmaceuticals (REGN)
Arthur J. Gallagher & Co. (AJG)
D.R. Horton (DHI)
Comcast Corp Cl A (CMCSA)

View all positions for Y-Intercept

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management
Affinity Asset Advisors
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Samlyn Capital

View all funds holding Nurix Therapeutics